Human Tissue Research Network

The Summit 2010

Thank you for your interest in The Summit 2010

The Human Tissue Research Network Summit - A Vision For The New Decade is an invitation-only event and will take place in Cambridge, UK on 25-26 February 2010

On the first day of the Summit leading speakers and delegates will come together to discuss human tissue research in 2010 – a situational analysis of where we are now, progress made so far and the challenges of the current environment

Tissue Based Research in 2010 – Where Are We Now
Dr Bob Coleman, Science Advisor, Safer Medicines Trust

Therapeutic Challenges

Focus On Neurology
Dr Rivka Ravid, Director Brain Bank Consultants / Neuroscientists/Expert and Senior Scientist at Netherlands Institute for Neurosciences  

Human Tissue Based Research at Novo Nordisk A/S
Dr Ditte Tornehave, Senior Research Scientist, Histology, Biopharmaceutical Research Unit, Novo Nordisk A/S

The Use of Histopathology In Oncology Drug Development
Neil Gray, Team Leader Immunohistochemistry and Histopathology, AstraZeneca

Removing The Barriers To Human Tissue Research Across Europe
Professor Chris Foster, Professor of Cellular Pathology and Molecular
Genetics, Liverpool University

Panel Discussion And Q&A : The Challenges To Greater Use Of Human Tissues In Drug Discovery And Development In 2010
Chaired by Dr Julian Beesley, Apis BBI

Panel:

Dr Bob Coleman, Science Advisor, Safer Medicines Trust
Dr Rivka Ravid, Director Brain Bank Consultants / Neuroscientists/Expert and Senior scientist at Netherlands institute for Neurosciences
Professor Chris Foster, Professor of Cellular Pathology and Molecular
Genetics, Liverpool University
Professor Gerry A Thomas, Chair in Molecular Pathology, Division of
Investigative Science, Imperial College, London

Dinner Keynote Speaker

Solving The Issue Of Tissue At The National Level – What Can Be Learned From The Welsh Experience

Day two of the Summit will focus on a new vision for a new decade in human tissue based research

Presentations and discussions will cover solutions, including innovations in tissue banking technology, best practice, and how we can create an environment that works for all stakeholders and enables medical advancements

Innovations In Tissue Banking Technologies
Matthew Durdy, CEO, AQIX

Human Embryonic Stem Cell Derived Cardiomyocytes, Sensitive Tools For Cardiac Safety Screening
Arthur M. "Buzz" Brown, M.D, Ph.D, President and CEO, ChanTest Corporation

The Relevance Of Standardized Tissue Collection In A Clinical Trial
Dr Michael Stumm, Senior Biomarker Experimental Leader for Oncology, Roche

Ex Vivo Pharmacology With Fresh Tumors
Dr Hans Winkler, Senior Director, Head of Oncology Biomarker Development,
Ortho Biotech Oncology Research and Development, Johnson and Johnson

Panel Discussion And Q&A : 2010 onwards... A New Vision For A New Decade
Chairman: Dr Bob Coleman, Science Advisor, Safer Medicines Trust

Panel:

Professor Chris Foster, Professor of Cellular Pathology and Molecular
Genetics, Liverpool University
Dr Hans Winkler, Senior Director, Head of Oncology Biomarker Development,
Ortho Biotech Oncology Research and Development, Johnson and Johnson
Dr Michael Stumm, Senior Biomarker Experimental Leader for Oncology, Roche
Dr Cathy Prescott, Founder Biolatris Ltd & Chair of the UK National Stem
Cell Network Advisory Committee

Registration price GBP 249.00 plus VAT per person. Allocation will be on a first come, first served basis.

We look forward to seeing you at the Summit!